Aventis Pharma Q2 net up 17% to Rs 50 cr

Aventis Pharma today said its net profit rose by 17% year-on-year to Rs 50 crore for the quarter ended June 30, 2011.

The company had posted a net profit of Rs 42 crore for the quarter ended June 30, 2010, Aventis Pharma said in a filing to the Bombay Stock Exchange (BSE).

Net sales of the company rose to Rs 303 crore for the quarter ended June 30, 2011, from Rs 271.5 crore for the corresponding period of the previous fiscal.

The company's board has also declared an interim dividend of Rs 4 per equity share of Rs 10 face value, Aventis said.

Shares of Aventis Pharma were trading at Rs 2,105 per share in the afternoon on the BSE today, down 1.5% from their previous close.